E.J. Brandreth has been appointed vice president of Quality at Inovio Pharmaceuticals, Inc. Mr. Brandreth will be responsible for all quality and compliance functions for clinical trials and scaling up manufacturing and other operations to support the company’s pipeline of immunotherapies and DNA vaccines. He reports to Inovio's chief operating officer, Dr. Niranjan Sardesai.
Prior to joining Inovio, Mr. Brandreth had a successful career transitioning start-up clinical biotech operations into commercial entities, and supported the growth of several pharma companies in quality and compliance areas. Most recently, he served as senior vice president of Quality and Regulatory Affairs at Ajinomoto Althea, and previously held similar positions with IDEC, BioMarin and Favrille, Inc.